Epilepsy Devices Market Anticipated to Gain $1157.58 Million by 2028

A recent study by Triton Market Research titled Global Epilepsy Devices Market includes the Global Analysis and Forecasts by Application (Accelerometer, Deep Brain Stimulation [Epilepsy, Movement Disorders], Vagus Nerve Stimulation, Responsive Neurostimulation), Device Type (Implantable Devices, Wearable Devices [Bracelets, Watches, Mattress Devices, Anti-suffocation Pillows, Camera Devices, Other Wearable Devices], Traditional Devices), End-user (Homecare Settings, Neurology Centers, Hospitals & Clinics, Other End-users), Detection and Prediction Device Type (Electroencephalogram, Implanted Advisory Systems, Surface Electromyography, Intracranial EEG, Electrocardiography, Video Detection Systems, Electrodermal Activity, Other Detection and Prediction Device Types), and Regional Outlook (Europe, Asia-Pacific, Middle East and Africa, North America, Latin America).

The epilepsy devices help in the early diagnosis of seizures caused by epilepsy. They are offered to various end-users such as homecare settings, neurology centers, hospitals & clinics, and other end-users.

Request a Free Sample of the Global Epilepsy Devices Market Report @ https://www.tritonmarketresearch.com/reports/epilepsy-devices-market#request-free-sample

Triton Market Research's report highlights that the global epilepsy devices market is anticipated to progress at a CAGR of 8.16%, reaching a revenue worth $1157.58 million by 2028.

According to the World Health Organization (WHO), over 50 million individuals worldwide suffer from epilepsy, making it one of the most prevalent neurological conditions. Increased risk of endemic diseases such as malaria or neurocysticercosis, increased birth and traffic-related injuries, and disparities in medical infrastructure are anticipated to increase the incidences of seizures. Thus, the rise in the occurrence of diseases globally contributes to the growth of the epilepsy devices market.

However, stigma, misinformation, and misconceptions around epilepsy have fueled prejudice and discrimination against those diagnosed with this disease. Considerations for health literacy and audience demographics are important to increase public awareness and knowledge about the disease. Therefore, unawareness among the general masses about diseases is a factor that restricts the development of the global epilepsy devices market.

The epilepsy devices market is divided into application, device type, end-user, and detection & prediction device type. The application is segmented into accelerometer, deep brain stimulation, vagus nerve stimulation, and responsive neurostimulation. Deep brain stimulation is bifurcated into epilepsy and movement disorders. The device type is sectioned into implantable devices, wearable devices, and traditional devices. The wearable devices are divided into bracelets, watches, mattress devices, anti-suffocation pillows, camera devices, and other wearable devices.

Based on end-user, the market is divided into homecare settings, neurology centers, hospitals & clinics, and other end-users. Lastly, based on detection and prediction device type, it includes electroencephalogram, implanted advisory systems, surface electromyography, intracranial EEG, electrocardiography, video detection systems, electrodermal activity, and other detection and prediction device types.

North America leads the epilepsy devices market globally. The region's stronghold is mainly due to developed healthcare infrastructure, favorable government policies, and the rising prevalence of epilepsy cases. An estimated 1.2% of the US population has active epilepsy, accounting for around 3.4 million people. As a result, the region's key players invest heavily in R&D to develop new products, obtain approvals, and integrate innovative technologies. Thus, the aforementioned factors are expected to boost the growth of the epilepsy devices market in the region.

The key players in the epilepsy devices market include Natus Medical Incorporated, LivaNova Plc, Nihon Kohden Corporation, NeuroPace Inc, Compumedics Limited, Cadwell Industries Inc, Medtronic Plc, Empatica Inc, Neurosoft, Koninklijke Philips NV, Boston Scientific Corporation, Drägerwerk AG & Co KGaA, and Shenzhen Mindray Bio-Medical Electronics Co Ltd.

Purchase this Report @ https://www.tritonmarketresearch.com/reports/epilepsy-devices-market#purchase-option

Question & Answer: Epilepsy Devices Market

Question 1: Which factors contribute to the growth of the global epilepsy device market?
Answer: According to the World Health Organization (WHO), over 50 million individuals worldwide suffer from epilepsy, making it one of the most prevalent neurological conditions. Increased risk of endemic diseases such as malaria or neurocysticercosis, increased birth and traffic-related injuries, and disparities in medical infrastructure are anticipated to increase the incidences of seizures. Thus, the rise in the occurrence of diseases globally contributes to the growth of the epilepsy devices market.

Question 2: Which factors restrict the development of the global epilepsy device market?
Answer: Stigma, misinformation, and misconceptions around epilepsy have fueled prejudice and discrimination against those diagnosed with this disease. Considerations for health literacy and audience demographics are important to increase public awareness and knowledge about the disease. Therefore, unawareness among the general masses about diseases is a factor that restricts the development of the global epilepsy devices market.

Question 3: Which region dominates the epilepsy device market?
Answer: North America leads the epilepsy devices market globally. The region's stronghold is mainly due to developed healthcare infrastructure, favorable government policies, and the rising prevalence of epilepsy cases. An estimated 1.2% of the US population has active epilepsy, accounting for around 3.4 million people. As a result, the region's key players invest heavily in R&D to develop new products, obtain approvals, and integrate innovative technologies. Thus, the aforementioned factors are expected to boost the growth of the epilepsy devices market in the region.

Question 4: Which are the key players in the epilepsy device market?
Answer: The key players in the epilepsy devices market include Natus Medical Incorporated, LivaNova Plc, Nihon Kohden Corporation, NeuroPace Inc, Compumedics Limited, Cadwell Industries Inc, Medtronic Plc, Empatica Inc, Neurosoft, Koninklijke Philips NV, Boston Scientific Corporation, Drägerwerk AG & Co KGaA, and Shenzhen Mindray Bio-Medical Electronics Co Ltd.

Related Report:

Global Bariatric Surgery Market 2019-2027 - https://www.tritonmarketresearch.com/reports/bariatric-surgery-market

The global bariatric surgery market is expected to advance at a CAGR of 9.41% during the forecast period of 2019-2027.

According to the Office of Disease Prevention and Health Promotion, more than 80% of adults in the Americas are not able to meet the guidelines for aerobic and muscle-strengthening activities. As the prevalence of obesity rises worldwide, the total number of bariatric surgeries is expected to rise, boosting the market during the forecast period.

Furthermore, the bariatric surgery market can capitalize on key opportunities such as technological advancements and increasing government initiatives to reduce obesity to achieve the projected growth.

Triton Market Research
196, wards wharf approach
London E16 2EQ
Phone: +44 7441 911839
Email: sales@tritonmarketresearch.com
Website: https://www.tritonmarketresearch.com/

Triton is a leading market research company providing clients with the best online market research data reports. Our offerings include syndicated market insights, customized research reports, and cost-effective consulting services for constructive decision-making.

This release was published on openPR.